Department of Defence Tender by Dg Armed Forces Medical Service (GEM/2025/B/5995062)
Nasal Decongestant adult drops (Xylometazoline HCl 0.1% w/v nasal drop) bottle of 10 ml

Tender Timeline
Tender Title: Nasal Decongestant Adult Drops
Reference Number: GEM/2025/B/5995062
The Department of Defence, under the Ministry of Defence, is seeking qualified suppliers to provide Nasal Decongestant adult drops containing Xylometazoline HCl 0.1% w/v in 10 ml bottles. This tender aims to fulfill an order for a total quantity of 57,100 units. The procurement process is guided by the principles of transparency, fairness, and competition, ensuring that the selected vendor meets the high standards expected by the Ministry of Defence.
Scope of Work and Objectives
Prospective bidders are expected to deliver Nasal Decongestant adult drops that comply with exact specifications and quality standards. The primary objective is to enhance access to essential nasal medication for patients, particularly in medical and emergency situations. The successful bidder must demonstrate the ability to meet the stipulated delivery timelines while adhering to pharmaceutical regulations and quality assurance protocols.
Eligibility Criteria
To qualify for submitting a bid, interested parties must fulfill several eligibility requirements:
- Be a legally registered entity within the relevant jurisdiction.
- Have experience in the production and supply of pharmaceutical products.
- Possess a valid manufacturing license and relevant certifications that ensure compliance with health and safety standards.
Technical Requirements
The technical specifications for the product include:
- Each bottle of Nasal Decongestant adult drops must contain Xylometazoline HCl at a concentration of 0.1% w/v.
- The formulation must comply with the standards set forth by relevant health authorities.
- Packaging should be robust and suitable for pharmaceutical products, ensuring preservation of product integrity.
Financial Requirements
Bidders must ensure they can meet the financial requirements outlined therein, which include providing adequate documentation of fiscal stability and the ability to manage large-scale production without compromising product quality.
Document Submission Details
All application documents must be submitted electronically through the designated government procurement platform. Submissions should include:
- Completed bid form.
- Proof of eligibility.
- Technical specifications.
- Financial guarantees.
Special Provisions
This tender has special provisions intended to support Micro, Small, and Medium Enterprises (MSEs) and start-ups, encouraging participation from businesses that align with governmental initiatives promoting local and small-scale industry success.
Evaluation Process
The evaluation of bids will be based on criteria including:
- Compliance with eligibility and technical requirements.
- Pricing structure and payment terms.
- Company qualifications and production capabilities.
Delivery Locations
Successful bidders will be responsible for delivering the requested quantities to specified locations as directed by the Department of Defence.
Contact Information
Please refer to the official department communications for queries and further information regarding this tender.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Additional Doc 1 (Requested in ATC)
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, possessing valid manufacturing licenses, and having relevant experience in pharmaceutical production. Bidders must also meet quality assurance standards and provide adequate proof of compliance with health and safety regulations.
Bidders should ensure that the Nasal Decongestant adult drops contain Xylometazoline HCl at 0.1% w/v. The product must meet local pharmaceutical standards, and all packaging should maintain the integrity and safety of the medication.
The payment terms will detail conditions regarding payment timelines upon delivery, including possible upfront payments, milestone payments during production, and the final payment upon successful delivery and acceptance by the Department of Defence.
Bids must be submitted electronically through the designated government procurement platform. Ensure that all required documentation is included, formatted correctly, and follows the submission guidelines provided in the tender documentation.
Yes, the tender includes provisions for Micro, Small, and Medium Enterprises (MSEs), aimed at encouraging participation from smaller businesses. This initiative promotes local production while ensuring that MSEs have fair opportunities in the procurement process, aligning with governmental objectives for economic development.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders